LLY

1,141.85

+4.79%↑

JNJ

231.01

-0.17%↓

ABBV

218.68

+2.43%↑

UNH

386.88

+1.29%↑

MRK

120.62

-0.54%↓

LLY

1,141.85

+4.79%↑

JNJ

231.01

-0.17%↓

ABBV

218.68

+2.43%↑

UNH

386.88

+1.29%↑

MRK

120.62

-0.54%↓

LLY

1,141.85

+4.79%↑

JNJ

231.01

-0.17%↓

ABBV

218.68

+2.43%↑

UNH

386.88

+1.29%↑

MRK

120.62

-0.54%↓

LLY

1,141.85

+4.79%↑

JNJ

231.01

-0.17%↓

ABBV

218.68

+2.43%↑

UNH

386.88

+1.29%↑

MRK

120.62

-0.54%↓

LLY

1,141.85

+4.79%↑

JNJ

231.01

-0.17%↓

ABBV

218.68

+2.43%↑

UNH

386.88

+1.29%↑

MRK

120.62

-0.54%↓

Home・Elenco Azioni・Lantheus Holdings Inc

Lantheus Holdings Inc

Aperta

SettoreSettore sanitario

98.44 -0.79

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

97.82

Massimo

100.15

Metriche Chiave
By Trading Economics
Entrata	64M 118M
Vendite	-29M 377M
P/E Media del settore	23.512 50.102
EPS	1.46
Margine di Profitto	31.383
Dipendenti	1,193
EBITDA	-17M 81M

Raccomandazioni
By TipRanks
Raccomandazioni	Fortemente da comprare
Previsioni per 12 mesi	+3.65% upside

Dividendi
By Dow Jones
Utili prossimi	5 ago 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	684M 6.4B
Apertura precedente	99.23
Chiusura precedente	98.44

Notizie sul Sentiment di mercato

By Acuity

18%

82%

23 / 344 Classifica in Healthcare

Lantheus Holdings Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

27 mag 2026, 21:33 UTC

Utili

Correction to Salesforce 1Q Sales, Profit Rise Article

27 mag 2026, 21:00 UTC

Acquisizioni, Fusioni, Takeovers

HCA Healthcare Agrees to Buy The College of Health Care Professions

27 mag 2026, 20:18 UTC

Utili

Salesforce 1Q Sales, Profit Rise Amid Agentforce Efforts

27 mag 2026, 23:49 UTC

Discorsi di Mercato

Nikkei Might Decline Amid Uncertainty Over Potential U.S.-Iran Peace Deal -- Market Talk

27 mag 2026, 23:39 UTC

Discorsi di Mercato

Congo Copper, Cobalt Mining Not yet Seen Affected by Ebola Outbreak -- Market Talk

27 mag 2026, 23:34 UTC

Discorsi di Mercato

Infratil's Longroad Energy Considers Data-Center Strategy -- Market Talk

27 mag 2026, 23:34 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

27 mag 2026, 23:08 UTC

Discorsi di Mercato

Chinese Coal-Mine Disruptions Could Be Major Supply Shock for Global Markets -- Market Talk

27 mag 2026, 22:21 UTC

Discorsi di Mercato

Salesforce Lays Out AI Monetization Strategy -- Market Talk

27 mag 2026, 21:29 UTC

Azioni calde

Stocks to Watch: Marvell Technology, PDD, Zscaler -- WSJ

27 mag 2026, 21:08 UTC

Utili

Marvell's Data-Center Boom Powers Earnings Beat. Its Stock Surges. -- Barrons.com

27 mag 2026, 21:02 UTC

Utili

Salesforce Stock Slides on Mixed Results. CFO Touts New Pricing Model. -- Barrons.com

27 mag 2026, 20:59 UTC

Acquisizioni, Fusioni, Takeovers

What to Know About Pasqal, the Quantum Start-Up Going Public Soon -- Barrons.com

27 mag 2026, 20:55 UTC

Utili

Snowflake Stock Jumps 34%. How Amazon and an Earnings Beat Are Fueling the Gains. -- Barrons.com

27 mag 2026, 20:50 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

27 mag 2026, 20:48 UTC

Utili

Marvell's Data-Center Boom Powers Earnings Beat -- and a Big Stock Surge -- Barrons.com

27 mag 2026, 20:45 UTC

Utili

Marvell Stock Jumps on Earnings. Data-Center Revenue Is Still Booming. -- Barrons.com

27 mag 2026, 20:34 UTC

Acquisizioni, Fusioni, Takeovers

Webster Financial Stockholders Approve Sale to Banco Santander

27 mag 2026, 20:32 UTC

Utili

Acquisizioni, Fusioni, Takeovers

Synopsys Shares Fall Despite Earnings Beat With AI and Merger in Focus -- Barrons.com

27 mag 2026, 20:32 UTC

Acquisizioni, Fusioni, Takeovers

HCA Healthcare to Acquire The College of Health Care Professions for Undisclosed Terms >HCA

27 mag 2026, 20:32 UTC

Acquisizioni, Fusioni, Takeovers

HCA Healthcare: Eric Bing Will Continue to Lead CHCP as Chancellor and CEO >HCA

27 mag 2026, 20:30 UTC

Utili

Snowflake Beats Expectations and Expands AWS Ties Amid Software Sector Turmoil -- Barrons.com

27 mag 2026, 20:30 UTC

Acquisizioni, Fusioni, Takeovers

HCA Healthcare Announces Agreement To Acquire The College Of Health Care Professions >HCA

27 mag 2026, 20:22 UTC

Utili

Salesforce Stock Slides on Mixed Results -- Barrons.com

27 mag 2026, 20:16 UTC

Utili

Salesforce Stock Slides on Mixed Results -- Barrons.com

27 mag 2026, 20:13 UTC

Utili

Synopsys Sees 3Q Adj EPS $3.63-Adj EPS $3.69 >SNPS

27 mag 2026, 20:13 UTC

Utili

Marvell Revenue Beats Estimates. The Stock Rises. -- Barrons.com

27 mag 2026, 20:13 UTC

Utili

Synopsys Sees FY Adj EPS $14.72-Adj EPS $14.80 >SNPS

27 mag 2026, 20:12 UTC

Utili

Synopsys Sees FY EPS $2.49-EPS $2.91 >SNPS

27 mag 2026, 20:12 UTC

Utili

Synopsys Sees 3Q EPS 84c-EPS 98c >SNPS

Confronto tra pari

Modifica del prezzo

Lantheus Holdings Inc Previsione

Obiettivo di Prezzo

By TipRanks

3.65% in crescita

Previsioni per 12 mesi

Media 103.71 USD 3.65%

Alto 115 USD

Basso 90 USD

Basato su 9 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Lantheus Holdings Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

9 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 9 che hanno fornito valutazioni azionarie a Lantheus Holdings Inc - Dist negli ultimi 3 mesi.

Sentiment

By Acuity

23 / 344 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Lantheus Holdings Inc

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer. The company also offers Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and aPROMISE, an artificial intelligence medical device software; and PYLARIFY AI, an AI-based medical device software to perform quantitative assessment of PSMA PET/CT images in prostate cancer. In addition, it develops 1095, a PSMA-targeted iodine-131-labeled small molecule; PNT2002, a radiopharmaceutical therapy to treat mCRPC; PNT2003, an SSTR therapy that treats patients with SSTR-positive neuroendocrine tumors; MK-6240, a F 18-labeled PET imaging agent that targets Tau tangles in Alzheimer's disease; LNTH-1363S, an fibroblast activation protein, alpha targeted, copper-64 labeled PET imaging agent; and flurpiridaz used to assess blood flow to the heart;. It has collaboration agreements with GE Healthcare; NanoMab Technology Limited; Curium; RefleXion Medical, Inc.; POINT; Regeneron Pharmaceuticals, Inc; and Ratio Therapeutics LLC. The company was founded in 1956 and is based in Bedford, Massachusetts.